CSPC PHARMACEUTICAL GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.62 HKD | -1.05% |
|
-2.07% | -8.82% |
| 05-17 | CSPC Pharma Gets Clearance for China Clinical Trial of Drug for Metabolism-Related Diseases | MT |
| 05-14 | CSPC Pharma's Flu Medication Gets Registration Approval in China | MT |
| Sales 2024 * | 37.57B 4.82B 379B | Sales 2025 * | 40.68B 5.21B 411B | Capitalization | 78.41B 10.05B 791B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.11B 912M 71.79B | Net income 2025 * | 7.68B 984M 77.47B | EV / Sales 2024 * | 1.63 x |
| Net cash position 2024 * | 17.2B 2.2B 174B | Net cash position 2025 * | 22.53B 2.89B 227B | EV / Sales 2025 * | 1.37 x |
| P/E ratio 2024 * |
11.1
x | P/E ratio 2025 * |
10.3
x | Employees | 23,500 |
| Yield 2024 * |
2.87% | Yield 2025 * |
3.14% | Free-Float | 70.15% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -1.05% | ||
| 1 week | -2.07% | ||
| Current month | +2.16% | ||
| 1 month | +13.94% | ||
| 3 months | +6.60% | ||
| 6 months | -2.22% | ||
| Current year | -8.82% |
1 week
6.54
6.90
1 month
5.656.90
Current year
5.567.37
1 year
5.207.75
3 years
5.2012.68
5 years
5.2012.68
10 years
2.7713.93
| Managers | Title | Age | Since |
|---|---|---|---|
Cui Long Zhang
CEO | Chief Executive Officer | 55 | 31/12/95 |
Dong Chen Cai
CHM | Chairman | 70 | 31/12/97 |
Hao Jiang
BRD | Director/Board Member | 41 | 31/07/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 70 | 31/12/97 |
Cheuk Kin Law
BRD | Director/Board Member | 61 | 07/03/21 |
Kin Man Chak
BRD | Director/Board Member | 58 | 31/12/04 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.05% | 2 M€ | -12.23% | - | |
| 2.02% | 4 M€ | -27.92% | ||
| 1.07% | 3 M€ | +10.86% | - | |
| 0.99% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/05/24 | 6.62 | -1.05% | 54,660,940 |
| 16/05/24 | 6.69 | -0.59% | 52,805,430 |
| 14/05/24 | 6.73 | -1.90% | 29,184,870 |
| 13/05/24 | 6.86 | 0.00% | 29,983,870 |
| 10/05/24 | 6.86 | +1.48% | 36,269,270 |
Delayed Quote Hong Kong S.E., May 17, 2024 at 09:08 am
More quotes
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:
- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);
- vitamin C (10.1%);
- antibiotics (6.2%);
- other (5%): including anhydrous and raw caffeine.
Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Sector
Pharmaceuticals
Calendar
21/05/2024
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
6.62
HKD
Average target price
9.382
HKD
Spread / Average Target
+41.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.82% | 10.16B | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
- Stock Market
- Equities
- 1093 Stock
